Thanks for posting this, and well, yes BUT to Magnoza... certainly the first and continuing priority is to sustain availability for testing on potential/suspected infected persons.
However the reason the new NEOKIT looks to be such a game changer is that beyond rapid testing of the possibly infected, is if there's a rapid test with high accuracy, inexpensive and better still if it works like a pregnancy test which can be done at home, then In that scenario one could (A) know if infected but not showing symptoms, (B) could increase and improve sociability if you and a friend or friends want to get close and socialize. For 600 pesos and a blue test result (test negative with the NEOKIT), join the party. It would go a long way to reduce some of the contemporary miserable angst of staying away from everyone or taking unknown risks and hoping for the best. If it's just a better testing method but restricted then okay, but if it opens a door to a new normal then barbaro!
I AGREE....
Also, supply and demand usually works to lower the price, not to increase the price - as long as the supply is there.
Not always in the realm of pharmaceuticals....and in Argentina it's no different. Hopefully, I am wrong.